Global Cord Blood (NYSE:CO) Coverage Initiated at StockNews.com

StockNews.com assumed coverage on shares of Global Cord Blood (NYSE:CO) in a report issued on Friday morning. The brokerage issued a strong-buy rating on the medical research company’s stock.

Global Cord Blood Price Performance

CO opened at $1.50 on Friday. The stock has a market capitalization of $182.33 million, a price-to-earnings ratio of 2.34 and a beta of 0.16. The business has a 50-day moving average of $1.23 and a two-hundred day moving average of $1.35. Global Cord Blood has a 12 month low of $2.03 and a 12 month high of $5.50.

About Global Cord Blood

Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants.